Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Gemzar

(JEM-zar)
A drug used alone or with other drugs to treat certain types of breast, non-small cell lung, ovarian, and pancreatic cancers that are advanced or have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Gemzar stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called gemcitabine hydrochloride and Infugem.
Search NCI's Dictionary of Cancer Terms